Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: 1) platforms for myeloma disease evaluation; 2) insights into pathophysiology; 3) therapeutic target and resistance mechanisms; and 4) cellular therapy for multiple myeloma. In the present report, we provide a comprehensive summary of these workshop presentations.

Original publication




Journal article


Transplant Cell Ther

Publication Date



CAR T-cell, imaging, multiple myeloma, resistance, tumor microenvironment